Aureocins A70, A53 and 215FN (aureus) Pep5, Epidermin K7 and Epicidin 280 (epidermidis) |
II and I |
Staphylococcus aureus and Staphylococcus epidermidis |
(Lívio Varella Coelho et al. 2017LÍVIO VARELLA COELHO M, FREITAS DE SOUZA DUARTE A & DO CARMO DE FREIRE BASTOS M. 2017. Bacterial Labionin-Containing Peptides and Sactibiotics: Unusual Types of Antimicrobial Peptides with Potential Use in Clinical Settings (a Review). Curr Top Med Chem 17: 1177-1198.) |
Morricin 269, Kurstacin 287, Kenyacin 404, Entomocin 420 and Tolworthcin 524 |
II |
Bacillus thuringiensis
|
(Barboza-Corona et al. 2009BARBOZA-CORONA JE, DE LA FUENTE-SALCIDO N, ALVA-MURILLO N, OCHOA-ZARZOSA A & LÓPEZ-MEZA JE. 2009. Activity of bacteriocins synthesized by Bacillus thuringiensis against Staphylococcus aureus isolates associated to bovine mastitis. Vet Microbiol 138: 179-183. doi:10.1016/j.vetmic.2009.03.018.) |
Lysostaphin |
III |
Staphylococcus simulans biovar staphylolyticus
|
(Schindler & Schuhardt 1964SCHINDLER CA & SCHUHARDT VT. 1964. Lysostaphin: A new bacteriolytic agent for the staphylococcus. Proc Natl Acad Sci USA 51: 414-421. doi:10.1073/pnas.51.3.414., Lívio Varella Coelho et al. 2017LÍVIO VARELLA COELHO M, FREITAS DE SOUZA DUARTE A & DO CARMO DE FREIRE BASTOS M. 2017. Bacterial Labionin-Containing Peptides and Sactibiotics: Unusual Types of Antimicrobial Peptides with Potential Use in Clinical Settings (a Review). Curr Top Med Chem 17: 1177-1198.) |
Epidermicin NI01 |
|
Staphylococcus epidermidis |
(Sandiford & Upton 2012SANDIFORD S & UPTON M. 2012. Identification, Characterization, and Recombinant Expression of Epidermicin NI01, a Novel Unmodified Bacteriocin Produced by Staphylococcus epidermidis That Displays Potent Activity against Staphylococci. Antimicro. Agents Chemother 56: 1539-1547. doi:10.1128/AAC.05397-11.) |
Pediocina PA-1 |
II |
Lactococcus lactis
|
(Rodrı́guez et al. 2005) |
Nisin A, lacticin Q, and Nukacin ISK-1 |
I |
Lactococcus lactis QU 5 and Staphylococcus warneri ISK-1
|
(Okuda et al. 2013OKUDA K, ZENDO T, SUGIMOTO S, IWASE T, TAJIMA A, YAMADA S, SONOMOTO K & MIZUNOE Y. 2013. Effects of bacteriocins on methicillin-resistant Staphylococcus aureus biofilm. Antimicrob Agents Chemother 57: 5572-5579. doi:10.1128/AAC.00888-13.) |
Lacticin 3147 |
I |
Lactococcus lactis subsp. lactis
|
(Twomey et al. 2000TWOMEY DP, WHEELOCK AI, FLYNN J, MEANEY WJ, HILL C & ROSS RP. 2000. Protection against Staphylococcus aureus mastitis in dairy cows using a bismuth-based teat seal containing the bacteriocin, lacticin 3147. J Dairy Sci 83: 1981-1988. doi:10.3168/jds.S0022-0302(00)75075-2.) |
Enterocin CCM 4231 |
II |
Enterococcus faecium CCM 4231
|
(Lauková & Czikková 1999LAUKOVÁ A & CZIKKOVÁ S. 1999. The use of enterocin CCM 4231 in soy milk to control the growth of Listeria monocytogenes and Staphylococcus aureus. J Appl Microbiol 87 : 182-186. doi:10.1046/j.1365-2672.1999.00810.x.) |
E 50-52 and OR-70 |
II |
Enterococcus faecium NRRL B-30746 and Lactobacillus salivarius NRRL B-30514 |
(Svetoch et al. 2008SVETOCH EA ET AL. 2008. Diverse antimicrobial killing by Enterococcus faecium E 50-52 bacteriocin. J Agric Food Chem 56: 1942-1948. doi:10.1021/jf073284g., Hanchi et al. 2017HANCHI H, HAMMAMI R, GINGRAS H, KOURDA R, BERGERON MG, BEN HAMIDA J, QUELLETTE M & FLISS I. 2017. Inhibition of MRSA and of Clostridium difficile by durancin 61A: synergy with bacteriocins and antibiotics. Future Microbiol 12: 205-212. doi:10.2217/fmb-2016-0113.) |
Duracin 61A and Reuterin |
|
Enterococcus durans 61A and Lactobacillus reuteri
|
(Hanchi et al. 2017HANCHI H, HAMMAMI R, GINGRAS H, KOURDA R, BERGERON MG, BEN HAMIDA J, QUELLETTE M & FLISS I. 2017. Inhibition of MRSA and of Clostridium difficile by durancin 61A: synergy with bacteriocins and antibiotics. Future Microbiol 12: 205-212. doi:10.2217/fmb-2016-0113.) |
Pentocin JL-1 |
I |
Lactobacillus
pentosus
|
(Jiang et al. 2017JIANG H, ZOU J, CHENG H, FANG J & HUANG G. 2017. Purification, Characterization, and Mode of Action of Pentocin JL-1, a Novel Bacteriocin Isolated from Lactobacillus pentosus, against Drug-Resistant Staphylococcus aureus. BioMed Res Int 2017: 1-11. doi:10.1155/2017/7657190.) |
TA6 |
II |
Pseudomonas aeruginosa TA6 |
(Arumugam et al. 2019) |